172 related articles for article (PubMed ID: 10985327)
1. Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy.
Landau A; Batisse D; Piketty C; Jian R; Kazatchkine MD
AIDS; 2000 Aug; 14(12):1857-8. PubMed ID: 10985327
[No Abstract] [Full Text] [Related]
2. [Treatment of hepatitis C virus in HIV-positive patients].
Mallolas Masferrer J; Martínez-Rebollar M; Laguno Centeno M
Gastroenterol Hepatol; 2011 Oct; 34(8):558-67. PubMed ID: 21435743
[TBL] [Abstract][Full Text] [Related]
3. HIV and hepatitis C virus coinfection: bad bedfellows.
Schooley RT
Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
[TBL] [Abstract][Full Text] [Related]
4. HCV infection in the setting of HIV: prevalence, disease, treatment.
Laurence J
AIDS Read; 2006 Mar; 16(3):115-6. PubMed ID: 16538952
[No Abstract] [Full Text] [Related]
5. Impact of peginterferon alpha-2b and ribavirin treatment on liver tissue in patients with HCV or HCV-HIV co-infection.
Sarmento-Castro R; Horta A; Vasconcelos O; Coelho H; Mendez J; Tavares AP; Seabra J; Duarte M; Chaves L; Fortes O; Recalde C; Ventura A; Pires N; Pinho L; Dias N; Carneiro F
J Infect; 2007 Jun; 54(6):609-16. PubMed ID: 17194480
[TBL] [Abstract][Full Text] [Related]
6. Analysis of sequence configurations of the PKR-interacting HCV proteins from plasma and PBMC as predictors of response to interferon-alpha and ribavirin therapy in HIV-coinfected patients.
Bolcic F; Bull L; Martinez L; Reynoso R; Salomon H; Arduino R; Barnett B; Quarleri J
Intervirology; 2008; 51(4):261-4. PubMed ID: 18824873
[No Abstract] [Full Text] [Related]
7. Comment on Neumann et al. 'Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients'.
D'Offizi G; Martini F; Rozera G; Abbate I; Capobianchi MR; Narciso P; Dianzani F
AIDS; 2008 Jan; 22(2):321. PubMed ID: 18097242
[No Abstract] [Full Text] [Related]
8. New paradigms in the management of hepatitis C virus co-infections.
Sherman KE
Nat Clin Pract Gastroenterol Hepatol; 2007 Jan; 4 Suppl 1():S10-6. PubMed ID: 17235280
[TBL] [Abstract][Full Text] [Related]
9. Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?
Bani-Sadr F; Denoeud L; Morand P; Lunel-Fabiani F; Pol S; Cacoub P; Perronne C; Carrat F;
J Acquir Immune Defic Syndr; 2007 May; 45(1):123-5. PubMed ID: 17460476
[No Abstract] [Full Text] [Related]
10. [Difficulties of selecting patients to receive treatment against hepatitis C virus in patients with HIV coinfection].
Marcos Sánchez F; Albo Castaño MI; Martín Barranco MJ; Casallo Blanco S; Joya Seijo D; Del Valle Loarte P
Gastroenterol Hepatol; 2005; 28(6):363-4. PubMed ID: 15989822
[No Abstract] [Full Text] [Related]
11. Anti-HIV agents. Hepatitis C treatment and possible interactions with anti-HIV drugs.
TreatmentUpdate; 2004; 16(3):2-4. PubMed ID: 17216833
[No Abstract] [Full Text] [Related]
12. Opportunistic infections update.
Proj Inf Perspect; 1998 Dec; (26):5-6. PubMed ID: 11366497
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.
Dominguez S; Ghosn J; Valantin MA; Schruniger A; Simon A; Bonnard P; Caumes E; Pialoux G; Benhamou Y; Thibault V; Katlama C
AIDS; 2006 May; 20(8):1157-61. PubMed ID: 16691067
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or both.
Ballesteros AL; Miró O; López S; Fuster D; Videla S; Martínez E; Garrabou G; Salas A; Côté H; Tor J; Rey-Joly C; Planas R; Clotet B; Tural C
Antivir Ther; 2004 Dec; 9(6):969-77. PubMed ID: 15651755
[TBL] [Abstract][Full Text] [Related]
15. INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA.
Abutidze A; Bolokadze N; Chkhartishvili N; Sharvadze L; Tsertsvadze T
Georgian Med News; 2016 Mar; (252):10-5. PubMed ID: 27119828
[TBL] [Abstract][Full Text] [Related]
16. Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs?
Franchini M
Hematology; 2006 Jun; 11(3):209-13. PubMed ID: 17325964
[TBL] [Abstract][Full Text] [Related]
17. Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.
Pineda JA; Mira JA; Gil Ide L; Valera-Bestard B; Rivero A; Merino D; Girón-González JA; Ríos-Villegas MJ; González-Serrano M; Collado A; García-García JA; Carrillo-Gómez R; López-Cortés LF; Gómez-Mateos J
J Antimicrob Chemother; 2007 Dec; 60(6):1347-54. PubMed ID: 17938129
[TBL] [Abstract][Full Text] [Related]
18. [HIV/HCV coinfection: 40% of patients can successfully be treated].
Dtsch Med Wochenschr; 2004 Apr; 129(16):911. PubMed ID: 15134089
[No Abstract] [Full Text] [Related]
19. [HIV/HCV double infection: combination is a clear therapy option].
Reich B
Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1590. PubMed ID: 15274242
[No Abstract] [Full Text] [Related]
20. Management of hepatitis C in HIV infected and other immunocompromised individuals.
Seth AK
Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
